Treatment of type 2 diabetes mellitus and the incretin system
Whitehill, D.
South Dakota Medicine the Journal of the South Dakota State Medical Association 60(5): 197; 199
2007
ISSN/ISBN: 0038-3317 PMID: 17694940 Document Number: 606779
Document emailed within 1 workday
Related Documents
Scheen, A.J.; Radermecker, R.P.; Philips, J.C.; Paquot, N. 2007: Incretin mimetics and incretin enhancers for the treatment of type 2 diabetes Revue Medicale Suisse 3(122): 1884; 1886-1888Vilsbøll, T.; Knop, F.K. 2007: Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus Ugeskrift for Laeger 169(22): 2101-2105
Nicolucci, A.; Rossi, M.Chiara. 2008: Incretin-based therapies: a new potential treatment approach to overcome clinical inertia in type 2 diabetes Acta Bio-Medica: Atenei Parmensis 79(3): 184-191
Boucek, P. 2006: Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system Vnitrni Lekarstvi 52(9): 791-796
Brunton, S.A. 2013: Integrating incretin-based therapy into type 2 diabetes management Journal of Family Practice 62(6 Suppl Cme): S1-S8
Unger, J.; Nadeau, D.A. 2007: Defining the role of incretin mimetic therapy in the management of type 2 diabetes Journal of Family Practice 56(12 Suppl New): S4
Urakami, T.; Suzuki, J.; Mugishima, H.; Amemiya, S.; Sugihara, S.; Kawamura, T.; Kikuchi, T.; Sasaki, N.; Matsuura, N.; Kitagawa, T. 2012: Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan Pediatric Endocrinology Reviews: Per 10(Suppl 1): 51-61
Gorus, F.K. 1996: The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 58(5): 539-586
Kotanko, P.; Heiss, H.; Wild, W.; Wach, P.; Wiesspeiner, G.; Skrabal, F. 1990: System for documenting and optimizing metabolic control in type i diabetes mellitus Biomedizinische Technik. Biomedical Engineering 35(Suppl 2): 181-182
Cerón, J.ús.D.; Gutiérrez, M.F.; Gómez, G.; López, D.M.; Alvarez, R.E.; González, C.; Sierra-Torres, C.H. 2014: Design and implementation of a personal health record system for diabetes mellitus type 2 monitoring Studies in Health Technology and Informatics 200: 167-169
Koev, D.; Koeva, L.; Khristov, V.; Tsinlikov, I.; Simeononv, S.; Petkova, M.; Veleva, N. 2000: Consensus on the treatment of type 2 diabetes mellitus Vutreshni Bolesti 32(1): 29-31
Krairittichai, U.; Chaisuvannarat, V. 2009: Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy Journal of the Medical Association of Thailand 92(5): 611-617
Sugihara, S. 2016: Diagnosis and treatment of type 1 diabetes mellitus in children Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 2): 501-505
Baliga, B.S.; Fonseca, V.A. 1997: Recent advances in the treatment of type II diabetes mellitus American Family Physician 55(3): 817-824
Kvapil, M. 2019: Strategy and tactics of treatment of type 2 diabetes mellitus Vnitrni Lekarstvi 65(4): 273-278
Takanashi, K.; Inukai, T. 2000: Insulin resistance and changes in the blood coagulation-fibrinolysis system after a glucose clamp technique in patients with type 2 diabetes mellitus Journal of Medicine 31(1-2): 45-62
Kuznetsova, L.A.; Plesneva, S.A.; Sharova, T.C.; Pertseva, M.N. 2013: Study of hormone responsiveness of the adenylyl cyclase signaling system in erythrocyte membranes of patients with type 2 diabetes mellitus Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 45-49
Panchenko, V.M.; Ershov, A.A.; Isaev, V.A.; ZImovchenko, G.S.; Chernova, G.I. 2001: Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus Klinicheskaia Meditsina 79(6): 47-49
Fogari, R.; Zoppi, A.; Pasotti, C.; Nicrosini, S.; Lazzari, P.; Corradi, L. 1990: Ketanserin in chronic treatment of hypertension in type 2 diabetes mellitus International Journal of Clinical Pharmacology Therapy and Toxicology 28(5): 218-222
Kawamori, R. 2011: The expectation for DPP-4 inhibitors on future treatment of type 2 diabetes mellitus Nihon Rinsho. Japanese Journal of Clinical Medicine 69(8): 1515-1519